Home > Healthcare > Medical Devices > Therapeutic Devices > Renal Denervation Market
Key industry developments in the market include the continuous advancements in device technologies. Medtronic's Symplicity Spyral has received significant FDA approvals, establishing itself as a leader in the field. New innovations such as ultrasound-based devices from ReCor Medical and the ongoing clinical trials, including the SPYRAL HTN, have expanded the clinical applicability of renal denervation systems. Strategic partnerships between major players, such as the collaboration between Venus Medtech and Healium, further support market growth. Additionally, regulatory approvals in key markets are streamlining access to these technologies.
Prominent players operating in the renal denervation industry include: